Concepedia

Hongwei Lv

HL

Statistics

Publications

15

Citations

2.4K

H-Index

13

Active since

2016

Affiliations

Eastern Hepatobiliary Surgery Hospital(Current)

Second Military Medical University

Shanghai Cancer Institute

State Key Laboratory of Oncogene and Related Genes

Renji Hospital

Hongwei Lv is an author at Eastern Hepatobiliary Surgery Hospital specializing in oncology, medicine, and molecular oncology.

Publications per year

2016–2024

15

Publications

15

Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer

Tian Fang, Hongwei Lv, Guishuai Lv et al. · Nature Communications · 2018 · 1.1K citations · Full text

Medicine, Cancer Biology, Oncology +17

NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion

Hongwei Lv, Guishuai Lv, Cian Chen et al. · Cell Metabolism · 2020 · 302 citations · Full text

Medicine, Cancer Biology, Oncology +12

ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α

Fuquan Wu, Tian Fang, Le‐Xing Yu et al. · Journal of Hepatology · 2016 · 255 citations

Life Sciences, Cancer Biology, Pharmacology +16

Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2

Hongwei Lv, Changzheng Wang, Tian Fang et al. · npj Precision Oncology · 2018 · 172 citations · Full text

Medicine, Oncology, Pharmacology +16

Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation

Wei Xiang, Hongwei Lv, Fuxue Xing et al. · Science Advances · 2023 · 139 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 15